| A Urbano-Ispizua1, N Schmitz2, T de Witte3, F Frassoni4, G Rosti5, H Schrezenmeier6, E Gluckman7, W Friedrich8, C Cordonnier9, G Socie7, A Tyndall10, D Niethammer11, P Ljungman12, A Gratwohl13, J Apperley14, D Niederwieser15 and A Bacigalupo14 for the European Group for Blood and Marrow Transplantation |
1Dept of Hematology, Hospital Clinic, Barcelona, Spain
2Dept of Hematology, AK St Georg, Hamburg, Germany
3Dept of Hematology, University Medical Center St. Radboud, Nijmegen, The Netherlands
4Dept of Hematology, Ospedale San Martino, Genova, Italy
5Dept of Onco-Hematology, Ospedale Civile, Ravenna, Italy
6Dept of Hematology, Oncology, Transfusion Med, University Hospital Benjamin Franklin, Berlin, Germany
7Dept of Hematology, BMT Unit, Hôpital St. Louis, Paris, France
8Abt Pädiatrie II, University of Ulm, Ulm, Germany
9Dept of Hematology, Hôpital Henri Mondor, Créteil, France
10Reumatologische Universitätsklinik, Felix Platter Spital, Basel, Swizerland
11Dept of Pediatrics, University Hospital, Tübingen, Germany
12Dept of Hematology, Huddinge University Hospital, Huddinge, Sweden
13Dept of Hematology, Kantonsspital, Basel, Switzerland
14Dept of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, UK
15Div Internal Med II, University of Leipzig, Germany
|
The Accreditation Sub-Committee of the EBMT regularly publishes special reports on current practice of haemopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders. Major changes have occurred since the last report in 1998. Haemopoietic stem cell transplantation today includes allogeneic and autologous stem cells derived from bone marrow, peripheral blood and cord blood. With reduced intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged, such as autoimmune disorders and AL amyloidosis for autologous, and solid tumours for allogeneic transplants. Other indications, such as autologous transplantation for breast cancer have been challenged. An updated report with revised tables and operating definitions is presented here. Bone Marrow Transplantation (2002) 29, 639-646. DOI: 10.1038/sj/bmt/1703535 |
